4/A//SEC Filing
OBRIEN MORGAN E 4/A
Accession 0001209191-22-035272
CIK 0001304492other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 9:05 PM ET
Size
6.0 KB
Accession
0001209191-22-035272
Insider Transaction Report
Form 4/AAmended
Anterix Inc.ATEX
OBRIEN MORGAN E
DirectorVice Chairman of the Board
Transactions
- Award
Stock Option (Right to Buy)
2021-09-07+65,768→ 65,768 totalExercise: $60.92Exp: 2031-09-07→ Common Stock (65,768 underlying)
Footnotes (2)
- [F1]The prior Form 4 incorrectly reported the option grant for 65,595 shares.
- [F2]33 1/3% of the option shares vest and become exercisable on September 7, 2022 with the remaining shares vesting in 2 equal annual installments thereafter.
Documents
Issuer
Anterix Inc.
CIK 0001304492
Entity typeother
Related Parties
1- filerCIK 0000937846
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 9:05 PM ET
- Size
- 6.0 KB